Brown’s biotech startup to hire 225, invest $16M in HQ
A company founded a year ago by prominent local tech entrepreneur Don Brown expects to pay average salaries of $156,000 a year in new space at the IU Emerging Technology Center.
Life Science & Biotech
Articles
City files suit against drug manufacturers over opioid epidemic
The suit names two dozen entities, including Stamford, Connecticut-based Purdue Pharma LP—which produces OxyContin—as well as Cephalon Inc, Teva Pharmaceutical Industries Ltd., Johnson & Johnson and Janssen Pharmaceuticals.
Lilly Endowment gives AgriNovus $4.2M to aid public awareness campaign
AgriNovus Indiana wants to get the word out on the state’s agbiosciences efforts and the opportunities they offer across several agricultural and technological sectors.
West Lafayette biotech raises $40M to develop cancer-imaging drugs
The company said the funds would help it test its lead compound in late-stage clinical trials, allowing surgeons to detect cancerous cells with the help of fluorescent dyes.
Device maker SonarMed ponders whether to go solo or find a partner
The Carmel-based company makes a device that uses sound waves to help position and monitor breathing tubes for newborns in hospitals.
LifeOmic teams with IU, Regenstrief on precision medicine
The startup, founded by serial entrepreneur Don Brown, has hashed out a deal that it gives it access to a broad range of intellectual property.
Cook Group selling drug unit for $950M, buying former GE factory
Cook officials cast the sale of Cook Pharmica and the purchase of what once was the world’s largest refrigerator factory as good news for Bloomington.
Animal-health biz Elanco under the weather; Lilly won’t rule out spinoff
The Greenfield-based unit, which makes a vast array of vaccines, antibiotics, feed additives and other health products for livestock and pets, is in a slump, after more than a decade of growth.
Biosciences institute CEO steps down; chief scientist promoted to top spot
David Broecker was founding CEO of the four-year-old Indiana Biosciences Research Institute, which aims to bridge the gap between research universities and industry in life sciences.
Medicare ruling casts cloud over miniature-hospital movement
Whether so-called micro-hospitals can succeed financially might depend on whether they can meet Medicare’s definition of a hospital: a medical facility that dedicates the bulk of its services to inpatient care.
Dow Chemical, DuPont to close $62B merger Aug. 31
DuPont and Dow Chemical Co. say they have cleared all regulatory hurdles and will complete their planned merger at the end of the month.
DuPont gets boost from farmers as Dow merger nears closing
DuPont Co. saw seed sales rise in the second quarter—good news before it closes in on the historic $75 billion merger with Dow Chemical Co., the parent of Indianapolis-based Dow AgroSciences.
Lilly Endowment giving IU medical school $25M to fund life sciences initiatives
The grant from the Indianapolis-based philanthropic giant is aimed at bolstering Indiana’s stature as a life sciences research hub.
16 Tech innovation district gears up for work under new CEO
The 16 Tech innovation district, an ambitious economic development project in the works in Indianapolis for more than a decade, has hired a top executive whose goal is to turn the downtrodden area into a thriving center for entrepreneurship and innovation.
IU Health, competitors turn focus to improving experience for patients, families
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.
Danville firm grows as other states embrace controversial chemical cremation method
Bio-Response Solution’s flagship product liquefies human corpses, turning muscle, flesh and fat into a coffee-colored effluent that can be swirled down the drain.
State using big data to attack opioid epidemic
Indiana’s Management Performance Hub is organizing and analyzing data to help state agencies make better decisions about fighting the opioid scourge and other systemic problems.
Brown calls genomics startup ‘riskiest thing I’ve ever done’
LifeOmic is seeking to help doctors provide more precise treatments for patients by sequencing their DNA.
Lilly hires ‘powerhouse’ D.C. lobbyist
Leigh Ann Pusey will join Eli Lilly and Co. next month as senior vice president for corporate affairs and communications.
Carmel biotech firm lands $8M in venture capital, grant funds
Founded in 2006, Fast BioMedical Inc. plans to use the money to help advance clinical trials and hire additional workers. It develops technologies to measure blood volume and kidney function.